Efficacy of Methyl Aminolevulinate + Daylight in Patients With Facial Photodamage
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
Treatment of actinic damage has included multiple procedures but to date there is limited
scientific evidence to support the preferential use of one of these therapies according to
their efficacy, safety and pain tolerance by patients. This study aims to assess the efficacy
of methyl aminolevulinate + daylight vs placebo + daylight to treat facial photodamage
Phase:
Phase 2
Details
Lead Sponsor:
Fundación Dermabase
Collaborators:
Grupo de Investigacion Dermatologica (GRID) IPS Universitaria-Universidad de Antioquia